Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Ryman Healthcare Ltd (RH7.MU)

Compare
1.2500
0.0000
(0.00%)
As of April 9 at 5:29:07 PM GMT+2. Market Open.
Loading Chart for RH7.MU
  • Previous Close 1.2500
  • Open 0.0000
  • Bid 1.2500 x --
  • Ask 1.3520 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 2.7980
  • Volume 0
  • Avg. Volume 839
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 25, 2025 - May 29, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: RH7.MU

View More

Performance Overview: RH7.MU

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .

YTD Return

RH7.MU
46.40%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
6.94%

1-Year Return

RH7.MU
48.47%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
1.92%

3-Year Return

RH7.MU
77.20%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
1.12%

5-Year Return

RH7.MU
80.77%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
22.46%

Compare To: RH7.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RH7.MU

View More

Valuation Measures

Annual
As of 4/8/2025
  • Market Cap

    937.26M

  • Enterprise Value

    2.25B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.67

  • Price/Book (mrq)

    0.42

  • Enterprise Value/Revenue

    6.54

  • Enterprise Value/EBITDA

    389.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RH7.MU

View More

Company Insights: RH7.MU

Research Reports: RH7.MU

View More